Overview
Thomas Mark practices practicing medicine in Ballerup, Denmark.
His clinical expertise encompasses Low Blood Sugar, Type 2 Diabetes (T2D), Atopic Dermatitis, and Maturity Onset Diabetes of the Young.
He is actively involved in clinical research, co-authoring 21 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Thomas Mark
Is Thomas Mark a top-rated expert for Low Blood Sugar?
MediFind is an objective health platform that identifies experts based on real-world data. Thomas Mark is classified as an Experienced expert for Low Blood Sugar, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Thomas Mark participate in research or clinical trials?
Yes. Thomas Mark has published 21 articles and abstracts on conditions like Low Blood Sugar. You can view a list of Thomas Mark's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Atopic DermatitisMr. Mark isExperienced. Learn about Atopic Dermatitis.
- Low Blood SugarMr. Mark isExperienced. Learn about Low Blood Sugar.
- Maturity Onset Diabetes of the Young
- Type 2 Diabetes (T2D)Mr. Mark isExperienced. Learn about Type 2 Diabetes (T2D).